רדאר ניסויים קליניים

בטא

מתקדם

רדאר קליני AI מועמד לניסוי או מטופל מטפל במטופל איש מקצוע בתחום הבריאות איש מקצוע בתחום הביוטכנולוגיה משקיע בתחום הביוטכנולוגיה חוקר אחר
	כעת מוצגים ניסויים קליניים התואמים למיקום צרפת עבור ניאופלזיות. אני יכול/ה לעזור לך למצוא ניסויים קליניים במיקומים ספציפיים ולשתף תובנות רפואיות מקצועיות לגבי מצבים בריאותיים וטיפולים. במצב מתקדם תוכל/י לגשת לכלי סינון מוקדם חזקים, ויזואליזציות אינטראקטיביות, והתראות דוא"ל מותאמות אישית על עדכוני ניסויים.

כלי החיפוש תומך באנגלית בלבד. לחיפוש ושיחה בשפות אחרות, השתמש ברדאר קליני AI ובחר מסנני מצב רפואי ומיקום למטה.

חיפוש לפי מצב רפואי...

חיפוש לפי מילות מפתח...

חיפוש לפי מיקום, מוסד...

חיפוש לפי התערבות...

חיפוש לפי מזהה NCT...

כותרת המחקר	סטטוס
Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment (TROPHAMET) NCT04396223	מגייס
A Study of GSK5733584 in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2) NCT06796907	מגייס
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations NCT06581432	מגייס
A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine NCT06619509	פעיל, לא מגייס
A Study of Continued Treatment With Regorafenib in Participants With Solid Tumors Who Have Participated in Other Bayer Studies NCT06246643	פעיל, לא מגייס
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01) NCT06941272	מגייס
Study Evaluating the Safety and the Efficacy of Human T Lymphoid Progenitor (HTLP) Injection to Accelerate Immune Reconstitution After Umbilical Cord Blood (UCB) Transplantation in Adult Patients With Hematologic Malignancies (HTLP-ONCO) NCT04707300	מגייס
Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations (AcSé) NCT02304809	פעיל, לא מגייס
Study of Posaconazole Prophylaxis in Patients Receiving Hematopoietic Stem Cell Allograft (Allo-HSC) at High Risk of Invasive Fungal Infection (IFI) (POSALLO) NCT06541067	מגייס
Safety and Efficacy of SMART101 in Adult Patients With Hematological Malignancies After Haploidentical HSCT With Post-transplant Cyclophosphamide NCT05768035	מגייס
EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1) NCT06923761	מגייס
Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Metastases (LUTARTERIAL) NCT04837885	מגייס
A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma (MajesTEC-1) NCT04557098	פעיל, לא מגייס
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma (MonumenTAL-1) NCT04634552	מגייס
Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma (MajesTEC-1) NCT03145181	פעיל, לא מגייס
Efficacy of Adapted Physical Activity on a Walking Platform in Elderly Patients HOspitalized for Cancer Surgery (APPAHOCA-2) NCT06201884	מגייס
A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors. (MEDIOLA) NCT02734004	פעיל, לא מגייסתוצאות שפורסמו
A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors NCT07498725	טרם החל גיוס
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver) (MORPHEUS-LIVER) NCT04524871	מגייס
A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies (EDGE-Gastric) NCT05329766	פעיל, לא מגייס
A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor NCT04008797	פעיל, לא מגייס
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies. (TITANium) NCT06542250	מגייס
Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465) NCT04509700	פעיל, לא מגייס
Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors (IGNYTE-ESO) NCT03967223	פעיל, לא מגייס
Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Treated Advanced (Metastatic or Unresectable) Synovial Sarcoma or Myxoid/Round Cell Liposarcoma NCT06703346	פעיל, לא מגייס
Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma NCT05993299	פעיל, לא מגייסתוצאות שפורסמו
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells NCT03435796	מגייס
A MULTICENTER, SEEKING SIGNAL, RANDOMISED, OPEN-LABEL PHASE II OF RELATLIMAB AND NIVOLUMAB VS NIVOLUMAB ALONE IN LOCALLY ADVANCED CERVICAL CANCERS (COLIBRI-2) NCT06715241	פעיל, לא מגייס
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002) NCT06818643	מגייס
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study NCT04641247	מגייס
Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options (STARTRK-NG) NCT02650401	פעיל, לא מגייס
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed NCT06885034	מגייס
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms NCT01594723	פעיל, לא מגייס
DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer NCT06757244	מגייס
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01) NCT06926868	מגייס
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer (preEMBER) NCT07287098	טרם החל גיוס
A Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal Cancer (AZUR-1) NCT05723562	פעיל, לא מגייס
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) NCT04956640	מגייס
A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors (iintune-1) NCT04420884	פעיל, לא מגייס
Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study NCT04589845	מגייס
To Access the Safety and Effects of Intravenous Administration of VIR-5818 Alone and in Combination With Pembrolizumab in Adult Participants With Locally Advanced or Metastatic HER2-Expressing Cancers NCT05356741	מגייס
Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation (CY-MET-RIC) NCT06252870	מגייס
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5) NCT07492680	טרם החל גיוס
INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies NCT03838042	מגייס
International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma NCT02066220	פעיל, לא מגייס
Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment (MOST plus) NCT02029001	מגייס
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1) NCT03093116	מגייס
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations NCT04094610	מגייס
Durvalumab and Tremelimumab for Pediatric Malignancies NCT03837899	פעיל, לא מגייסתוצאות שפורסמו
A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies NCT07213830	מגייס

רדאר ניסויים קליניים

שלב

סוג

סוג המחקר

קבוצת גיל

מין ביולוגי

פלצבו

שלב

סוג

סוג המחקר

קבוצת גיל

מין ביולוגי